DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Author: Avi Kapoor | July 26, 2024 08:05am

U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday.

Shares of DexCom, Inc. (NASDAQ:DXCM) fell sharply during Friday's pre-market trading after the company reported worse-than-expected second-quarter revenue results and issued weak FY24 revenue guidance.

DexCom reported quarterly earnings of 43 cents per share, which beat the analyst consensus estimate of 39 cents. Quarterly sales came in at $1.004 billion which missed the analyst consensus estimate of $1.036 billion.

DexCom sees third-quarter revenue in a range of $975 million to $1 billion, versus the $1.15 billion estimate, and full-year revenue in a range of $4. billion to $4.05 billion, versus the $4.33 billion estimate.

DexCom shares dipped 37% to $68.00 in the pre-market trading session.

Here are some big stocks recording losses in today's pre-market trading session.

Zynex, Inc. (NASDAQ:ZYXI) shares declined 21.5% to $8.00 in pre-market trading after the company reported worse-than-expected second-quarter financial results.
Ur-Energy Inc. (NYSE:URG) shares fell 9.2% to $1.18 in pre-market trading after the company announced a proposed public offering of common shares.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) shares declined 9% to $36.99 in pre-market trading. Tandem Diabetes Care will release its second quarter results after the closing bell on Thursday, Aug. 1.
MacroGenics, Inc. (NASDAQ:MGNX) shares dipped 8.9% to $5.01 in pre-market trading after gaining 5% on Thursday.
Olin Corporation (NYSE:OLN) shares declined 8.1% to $44.15 in pre-market trading following a second-quarter earnings miss.
Carter’s, Inc. (NYSE:CRI) shares fell 7.4% to $55.40 in pre-market trading following weak quarterly sales.
Indivior PLC (NASDAQ:INDV) shares fell 4.4% to $12.52 in pre-market trading. Indivior shares jumped 20% on Thursday after the company reported better-than-expected second-quarter financial results and announced an accelerated $100 million share repurchase program.